stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Gross margin
ICON PLC's gross margin over the twelve months to 30 September 2026 was 23.4%, down 2.9 percentage points from fiscal 2025 (26.4%). Over the past ten years it has ranged from 26.4% (fiscal 2025) to 42.3% (fiscal 2016) — the current reading is the lowest in ten years. That is below the Diagnostics & Research industry median of 48.3% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 26.4% | (2.58) |
| FY2024 | 29.0% | (0.61) |
| FY2023 | 29.6% | 0.96 |
| FY2022 | 28.6% | 1.08 |
| FY2021 | 27.5% | (1.70) |
| FY2020 | 29.2% | (0.42) |
| FY2019 | 29.6% | (0.31) |
| FY2018 | 30.0% | (11.63) |
| FY2017 | 41.6% | (0.73) |
| FY2016 | 42.3% | 0.02 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 24.3% | 1.06 |
| Jun 2026 | 23.2% | (0.27) |
| Mar 2026 | 23.5% | 0.74 |
| Dec 2025 | 22.8% | (3.41) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 72.2% |
| ILMN Illumina, Inc. compare | 67.9% |
| GH Guardant Health, Inc. compare | 65.2% |
| QGEN QIAGEN N.V. compare | 62.2% |
| RVTY Revvity Inc. compare | 55.9% |
| CRL Charles River Laboratories International, Inc. compare | 33.3% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| LH Labcorp Holdings Inc. compare | 29.0% |
| ICLR ICON PLC | 23.4% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement